PHASE-II TRIAL OF IPROPLATIN IN ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK, ESOPHAGUS AND LUNG

被引：3

作者：

CAPPELAERE, P ^{[1
]}

GUIOCHET, N ^{[1
]}

BASTIT, P ^{[1
]}

FAVRE, R ^{[1
]}

VANDERBURG, M ^{[1
]}

GOUPIL, A ^{[1
]}

CHAUVERGNE, J ^{[1
]}

THOMAS, D ^{[1
]}

VANGLABBEKE, M ^{[1
]}

ARMAND, JP ^{[1
]}

机构：

[1] EORTC,CTR DATA,B-1200 BRUSSELS,BELGIUM

来源：

EUROPEAN JOURNAL OF CANCER | 1993年 / 29A卷 / 08期

关键词：

D O I：

10.1016/S0959-8049(05)80327-2

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1216 / 1216

页数：1

共 6 条

[1] PHASE-II STUDY OF IPROPLATIN (CHIP, JM-9) IN ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK [J].

ABELE, R ;

CLAVEL, M ;

MONFARDINI, S ;

BRUNTSCH, U ;

RENARD, J ;

VANGLABBEKE, M ;

PINEDO, HM .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (04) :387-389

[2]

ALSARRAF M, 1987, CANCER TREAT REP, V71, P723

[3] A STRATEGY FOR THE DEVELOPMENT OF 2 CLINICALLY ACTIVE CISPLATIN ANALOGS - CBDCA AND CHIP [J].

FOSTER, BJ ;

HARDING, BJ ;

WOLPERTDEFILIPPES, MK ;

RUBINSTEIN, LY ;

CLAGETTCARR, K ;

LEYLANDJONES, B .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1990, 25 (06) :395-404

[4] PHASE II STUDY OF IPROPLATIN (CHIP) IN PREVIOUSLY TREATED SMALL-CELL LUNG-CANCER [J].

GRANFORTUNA, JM ;

NEWMAN, N ;

GINSBERG, SJ ;

LOUIE, A ;

COMIS, RL ;

GULLO, JJ ;

POIESZ, BJ .

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1989, 12 (04) :355-357

[5] RANDOMIZED PHASE-II EVALUATION OF IPROPLATIN (CHIP) AND CARBOPLATIN (CBDCA) IN LUNG-CANCER - A SOUTHEASTERN CANCER STUDY-GROUP TRIAL [J].

KRAMER, BS ;

BIRCH, R ;

GRECO, A ;

PRESTRIDGE, K ;

DESIMONE, P ;

OMURA, G .

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1988, 11 (06) :643-645

[6] IPROPLATIN AND CARBOPLATIN INDUCED TOXICITIES - OVERVIEW OF PHASE-II CLINICAL-TRIAL CONDUCTED BY THE EORTC EARLY CLINICAL-TRIALS COOPERATIVE GROUP (ECTG) [J].

VANGLABBEKE, M ;

RENARD, J ;

PINEDO, HM ;

CAVALLI, F ;

VERMORKEN, J ;

SESSA, C ;

ABELE, R ;

CLAVEL, M ;

MONFARDINI, S .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (02) :255-262

← 1 →